Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | White Papers
Search Refinements

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
91-101 of 101 results
Peptides to Non-Peptides: Leads from Structureless Virtual Screening
| By Cresset
FieldPrints™ and field-based overlays have shown themselves to be a robust method for locationg new leads for medicinal chemistry programs. Unlike docking protocols, no x-ray protein information is required and only 2D structures are needed for two or more ligands known to act at the same site. Thus, the technique is applicable to many classes of target for which no acceptable lead-finding solution currently exists because the technique is based on the surface properties of molecules.
Drug Research > Drug Discovery & Development > White Papers
Profiling Pharmaceuticals with Neuronal Network Cultures
| By NeuroProof
Our advanced combination of primary neuronal cell cultures on MEA neurochips and sophisticated methods of data analysis is a major step forward in target validation, which remains as one of the bottlenecks in drug discovery.
Drug Research > Drug Discovery & Development > White Papers
Protecting Sensitive Information in Life Sciences Organisations
| By Brainloop
Critical business processes in biotech companies involve highly confidential, important documents that need to be safely accessed by external partners and potential licensees. Find a new way to protect this confidential documents.
Drug Research > Drug Discovery & Development > White Papers
ProtoDynamic Therapy: A Novel Therapeutic Concept for Inflammation and Cancer
| By BioCis Pharma
The newly introduced term protodynamic can be defined as a proton-derived force that produces a change in a living cell. The basic idea is to transport hydrogen ions (H+ or protons) from the mildly acidic extracellular medium into the cell, which causes intracellular acidification. The protodynamic mode of action and the efficacy of cis-UCA in various models of inflammation and cancer will be briefly presented in this paper.
Drug Research > Drug Discovery & Development > White Papers
Seamless Life Sciences Collaboration
| By Brainloop
Speeding up your time to market: Seamless online collaboration in the biopharmaceutical industry
Drug Research > Drug Discovery & Development > White Papers
Taming China's Clinical Trial 'Dragon'
| By World Courier
With a population in excess of 1.3 billion and low technical costs, China is a highly attractive venue for clinical trials. In this article, current regulations and permit requirements are examined and a transportation case study is presented. Local solutions and important considerations for choosing appropriate "in country" service providers are also discussed.
Drug Research > Drug Discovery & Development > White Papers
The Informed Design and Validation of Quality of Life Questionnaires and Rating Scales Using Rasch Analysis
| By Exploristics
This free white paper describes how some of the additional outputs from Rasch analysis can provide information beyond that of a simple analysis of the QoL data during the creation and validation of a new instrument or to understand and quantify responses following a clinical study.
Drug Research > Drug Discovery & Development > White Papers
The Urgent Need for Qualified Transportation Providers in Global Clinical Research
| By World Courier
In light of sobering statistics from the MHRA, WHO and others about the quality of temperature-controlled drugs and medicinal products arriving at global research sites, regulatory agencies and pharmaceutical companies alike are demanding that every party involved in the pharmaceutical supply chain conform to GxP guidelines. This article outlines the main precepts of GxP as it applies to the pharmaceutical transport industry and offers insight on securing the global CTM supply chain.
Drug Research > Drug Discovery & Development > White Papers
ClinicalBase Trial
| By BaseCon
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT solutions by using state-of-the-art technology combined with detailed knowledge of the requirements in the pharmaceutical sector.
Drug Research > Drug Discovery & Development > White Papers
SafetyBase Interchange
| By BaseCon
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT solutions by using state-of-the-art technology combined with detailed knowledge of the requirements in the pharmaceutical sector.
Drug Research > Drug Discovery & Development > White Papers
CaseBase Management
| By BaseCon
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT solutions by using state-of-the-art technology combined with detailed knowledge of the requirements in the pharmaceutical sector.
Drug Research > Drug Discovery & Development > White Papers
91-101 of 101 results